mannitol has been researched along with Delayed Hypersensitivity in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Goyal, DK; Kaur, S; Keshav, P | 1 |
Narins, RS | 1 |
Maddox, TG | 1 |
Collins, S; Coventry, B; Farrelly, M; Hersey, P; Hirst, D; Johnson, H; Menzies, SW; Nguyen, T | 1 |
Allred, JB; Celis, E; Creagan, ET; Ingle, JN; Kaur, JS; Loprinzi, CL; Markovic, SN; Nevala, WK; Pitot, HC; Pittelkow, MR; Rao, RD; Suman, VJ | 1 |
Lauressergues, H; Tarayre, JP; Vilain, P | 2 |
Crowe, PT; Lunn, PG; Marsh, MN; Neale, G; Northrop-Clewes, C; Sullivan, PB | 1 |
2 review(s) available for mannitol and Delayed Hypersensitivity
Article | Year |
---|---|
Minimizing adverse events associated with poly-L-lactic acid injection.
Topics: Cellulose; Cosmetic Techniques; Drug Compounding; Face; Female; Granuloma, Foreign-Body; HIV-Associated Lipodystrophy Syndrome; Humans; Hypersensitivity, Delayed; Injections, Subcutaneous; Lactic Acid; Mannitol; Massage; Polyesters; Polymers; Skin; Skin Aging; Skin Diseases | 2008 |
Adverse reactions to contrast material: recognition, prevention, and treatment.
Topics: Anaphylaxis; Calcium Channel Blockers; Contrast Media; Diuretics; Dose-Response Relationship, Drug; Drug Hypersensitivity; Extravasation of Diagnostic and Therapeutic Materials; Fluid Therapy; Furosemide; Glucocorticoids; Humans; Hypersensitivity, Delayed; Mannitol; Renal Insufficiency; Risk Factors | 2002 |
2 trial(s) available for mannitol and Delayed Hypersensitivity
Article | Year |
---|---|
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cytokines; Enzyme-Linked Immunosorbent Assay; Epitopes; Epitopes, T-Lymphocyte; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Inflammation; Interferon-gamma; Lymphocytes; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptides; Skin Neoplasms; Time Factors; Treatment Outcome | 2005 |
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Cancer Vaccines; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Humans; Hypersensitivity, Delayed; Immunophenotyping; Male; Mannitol; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Vaccines, Subunit | 2006 |
4 other study(ies) available for mannitol and Delayed Hypersensitivity
Article | Year |
---|---|
Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice.
Topics: Adjuvants, Vaccine; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cytokines; Female; Hypersensitivity, Delayed; Immunoglobulin G; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Male; Mannitol; Mice, Inbred BALB C; Nitric Oxide; Oleic Acids; Polysorbates; Reactive Oxygen Species; Spleen; Squalene | 2021 |
Mannitol and delayed hypersensitivity in the rat.
Topics: Animals; Arthritis, Experimental; Bordetella pertussis; Hypersensitivity, Delayed; Male; Mannitol; Pleurisy; Rats | 1978 |
Action of mannitol in various immunological experimental models.
Topics: Acute Disease; Anaphylaxis; Animals; Antibody Formation; Arthritis, Experimental; Blood Pressure; Bordetella pertussis; Freund's Adjuvant; Guinea Pigs; Hypersensitivity, Delayed; Inflammation; Mannitol; Mice; Ovalbumin; Passive Cutaneous Anaphylaxis; Phagocytosis; Pleurisy; Rats | 1979 |
Persistent diarrhea and malnutrition--the impact of treatment on small bowel structure and permeability.
Topics: Anti-Bacterial Agents; Antifungal Agents; Blood Proteins; Body Weight; Cell Membrane Permeability; Child, Preschool; Chloramphenicol; Diarrhea, Infantile; Female; Follow-Up Studies; Humans; Hypersensitivity, Delayed; Infant; Infant Food; Intestinal Mucosa; Intestine, Small; Lactulose; Macrolides; Male; Mannitol; Metronidazole; Nutrition Disorders; Polyenes; Tuberculin | 1992 |